ChemBriefAustralia's Telix Pharma Agrees to Buy Germany's ITM Isotope for About $1.65 Billion
Telix Pharmaceuticals agreed to acquire Germany-based ITM Isotope Technologies for approximately $1.65 billion to secure isotope supplies for its therapeutics pipeline. The deal values ITM shareholder
reuters · 2026-09-20 16:01